Table 1. Clinical trials of immunoradiotherapy.

Author	Diagnosis	Sample size	Treatment	Outcome
Formenti et al. (23)	Metastatic carcinoma lung, bladder, breast, thymicca, eccrineca	14	GM-CSF + RT 3.5 Gy × 10#	30% patients showed abscopal effect, five patients had metabolic response in non-irradiated area
Chi et al. (24)	Hepatoma	14	8 Gy RT + intratumoral injection of immature dendritic cells	12 out of 14 patients had partial response
Postow et al. (25)	Metastatic melanoma	1	Ipilimumab + RT 28.5 Gy in 3#	Stable minimal disease in non-irradiated part after 10 months of irradiation
Hiniker et al. (26)	Metastatic melanoma	1	Ipilimumab + RT 54 Gy in 3#	Complete response in primary and metastatic site
Slovin et al. (27)	Metastatic castration resistant prostate cancer	50	Ipilimumab + RT	One patient had complete response, six had stable disease and eight showed good biochemical response

^#, fractions. RT, radiotherapy.